| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,428 |
2,258 |
$141K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,334 |
1,233 |
$44K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
94 |
92 |
$38K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
313 |
288 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
319 |
297 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
226 |
213 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
64 |
64 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
106 |
92 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
289 |
264 |
$880.58 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$414.72 |
| 96127 |
|
78 |
40 |
$323.60 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
41 |
40 |
$301.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$197.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
107 |
106 |
$127.33 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
72 |
71 |
$101.51 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
70 |
69 |
$12.23 |